DCM
GBT
Driehaus Capital Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-805,861
| Closed | -$25.7M | – | 430 |
|
|
2022
Q2 | $25.7M | Buy |
+805,861
| New | +$25.7M | 0.42% | 71 |
|
|
2020
Q4 | – | Sell |
-3,902
| Closed | -$215K | – | 487 |
|
|
2020
Q3 | $215K | Sell |
3,902
-235,196
| -98% | -$13M | ﹤0.01% | 379 |
|
|
2020
Q2 | $15.1M | Sell |
239,098
-134,786
| -36% | -$8.51M | 0.37% | 84 |
|
|
2020
Q1 | $19.1M | Buy |
373,884
+16,974
| +5% | +$867K | 0.64% | 40 |
|
|
2019
Q4 | $28.4M | Buy |
356,910
+186,451
| +109% | +$14.8M | 0.75% | 27 |
|
|
2019
Q3 | $8.27M | Sell |
170,459
-39,338
| -19% | -$1.91M | 0.27% | 102 |
|
|
2019
Q2 | $11M | Buy |
209,797
+59,655
| +40% | +$3.14M | 0.35% | 78 |
|
|
2019
Q1 | $7.95M | Sell |
150,142
-4,380
| -3% | -$232K | 0.3% | 96 |
|
|
2018
Q4 | $6.34M | Sell |
154,522
-40,694
| -21% | -$1.67M | 0.27% | 107 |
|
|
2018
Q3 | $7.42M | Sell |
195,216
-107,313
| -35% | -$4.08M | 0.23% | 137 |
|
|
2018
Q2 | $13.7M | Buy |
302,529
+15,658
| +5% | +$708K | 0.46% | 54 |
|
|
2018
Q1 | $13.9M | Buy |
286,871
+38,242
| +15% | +$1.85M | 0.49% | 43 |
|
|
2017
Q4 | $9.78M | Buy |
248,629
+84,275
| +51% | +$3.32M | 0.37% | 65 |
|
|
2017
Q3 | $5.1M | Buy |
164,354
+6,893
| +4% | +$214K | 0.2% | 140 |
|
|
2017
Q2 | $4.31M | Buy |
157,461
+11,879
| +8% | +$325K | 0.16% | 152 |
|
|
2017
Q1 | $5.37M | Buy |
+145,582
| New | +$5.37M | 0.18% | 126 |
|
|
2016
Q4 | – | Sell |
-374,108
| Closed | -$8.62M | – | 664 |
|
|
2016
Q3 | $8.62M | Buy |
374,108
+229,196
| +158% | +$5.28M | 0.29% | 69 |
|
|
2016
Q2 | $2.4M | Sell |
144,912
-882
| -0.6% | -$14.6K | 0.09% | 240 |
|
|
2016
Q1 | $2.31M | Sell |
145,794
-55,468
| -28% | -$880K | 0.07% | 263 |
|
|
2015
Q4 | $6.51M | Sell |
201,262
-42,137
| -17% | -$1.36M | 0.22% | 107 |
|
|
2015
Q3 | $10.3M | Buy |
+243,399
| New | +$10.3M | 0.37% | 65 |
|